نتایج جستجو برای: acinetobacter baumanni
تعداد نتایج: 10577 فیلتر نتایج به سال:
Acinetobacter; Nosocomial infections; Multi-drug resistance; Epidemiology; Characteristics Abstract The genus Acinetobacter is a major cause of nosocomial infections; it is increasingly being associated with various epidemics and has become a widespread concern in a variety of hospitals worldwide. Multi-antibiotic resistant Acinetobacter baumannii, is now recognized to be of great clinical sign...
Multiple antibiotic resistance threatens successful treatment of Acinetobacter baumannii infections worldwide. Increasing interest in the well-known activity of sulbactam against the genus Acinetobacter has been aroused. The purpose of this study was to compare the outcomes for patients with Acinetobacter bacteremia treated with cefoperazone/sulbactam versus imipenem/cilastatin. Forty-seven pat...
Here we report the draft genome sequence of one Acinetobacter genomic species 3 strain, D499, which harbors the bla(NDM-1) gene. The total length of the assembled genome is 4,103,824 bp, and 3,896 coding sequences (CDSs) were predicted within the genome. A previously unreported bla(NDM-1)-bearing plasmid was identified in this strain.
Background & Aims: Acinetobacter spp. are non-fermenting gram-negative coccobacilli that have emerged in recent three decades as major causes of nosocomial infections. Acinetobacter baumannii is the most common pathogen causing a wide spectrum of infections. Acinetobacter infections are difficult to treat, due to both the intrinsic resistance of the pathogen and its ability to readily acquire n...
Abstract Background and Objective: Acinetobacter species are opportunistic important pathogens responsible for many nosocomial infections. The purpose of this study was to determine the drug resistan pattern Acinetobacter baumannii and prevalence of ESBL producing strains in Intensive Care Unit patients in Isfahan city hospitals. Material and Methods: The study was conducted on 100 Ac...
Acinetobacter is an aerobic, non-fermentative gramnegative bacillus, which is widespread in nature (1). Acinetobacter has been recognized as a pathogen which plays a significant role in the colonization and infection in immunocompromised patients. Acinetobacter has been implicated in a variety of nosocomial infections, including bacteremia, urinary tract infection, and ventilator-associated pne...
We report the 3.78-Mbp high-quality draft assembly of the genome from a clinical isolate of Acinetobacter nosocomialis called strain M2 (previously known as Acinetobacter baumannii strain M2).
OBJECTIVE To test the activity of a small molecule compound that targets Lipid II against Acinetobacter baumannii. METHODS Susceptibility to small molecule Lipid II inhibitor BAS00127538 was assessed using carbapenem- and colistin-resistant clinical isolates of A. baumannii. In addition, synergy between colisitin and this compound was assessed. RESULTS Small molecule Lipid II inhibitor BAS0...
Acinetobacter baumannii is a successful nosocomial pathogen due to its ability to persist in hospital environments by acquiring mobile elements such as transposons, plasmids, and phages. In this study, we compared two genomes of A. baumannii clinical strains isolated in 2000 (ST-2_clon_2000) and 2010 (ST-2_clon_2010) from GenBank project PRJNA308422.
A new site-specific restriction endonuclease, AccIII, was isolated from Acinetobacter calcoaceticus. AccIII recognizes T/CCGGA and cleaves at the position shown by the arrow. AccIII activity was inhibited by adenine methylation at the overlapping dam methylase recognition sequence.
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید